Patent · US Active

Pyruvate kinase activators for use in treating blood disorders

US12133853B2 · kind B2 · utility

0Cited by

6References

25Claims

0Family size

Assignee

Agios Pharmaceuticals, Inc. · US

Inventors

Giovanni Cianchetta · Waltham, US
Tao Liu · Shanghai, CN
Anil Kumar Padyana · Oxford, US
Zhihua Sui · Flemington, US
Zhenwei Cai · Skillman, US
Dawei Cui · Shanghai, CN
Jingjing Ji · Shanghai, CN

Key dates

Filing date	Jan 20, 2023
Grant date	Nov 5, 2024
Priority date	—
Expiry date	Jan 20, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are compounds that activate pyruvate kinase, pharmaceutical compositions and methods of use thereof. These compounds are represented by Formula (I) wherein R1, R2, Ra, Rb, Rj, Rk, and Q are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.